SAR-97276

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameSAR-97276
Drug Alias NameSAR-97276SAR-97276A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAcetylcholine receptor; alpha1/beta1/delta/gamma antagonists
TargetsAcetylcholine receptor; alpha1/beta1/delta/gamma
Therapy Area/IndicationsMalaria
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBeninTanzaniaBurkina Faso +[5] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofi
Active IndicationsN/A
Inactive IndicationsMalaria

Other Information

ATC CodeN/A
Related LinksN/A